Literature DB >> 2182594

Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phase.

R T Silver1.   

Abstract

Although chronic myeloid leukemia is an incurable disease for the majority of patients, striking advances in our understanding of cell biology, molecular genetics, and new treatment programs involving interferon and bone marrow transplantation have led to clinical improvement for a small number of patients afflicted with this disease. Nevertheless, hope exists that such basic and clinical information will be expanded to a larger number of patients in the near future.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182594

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  1 in total

1.  Atypical chronic myelogenous leukemia in a patient with trisomy 8 mosaicism syndrome.

Authors:  P Kapaun; H Kabisch; K R Held; T A Walter; S Hegewisch; A R Zander
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.